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Abstract
This article is part of a series written for people responsible for making decisions about health policies and
programmes and for those who support these decision makers.
Policy dialogues allow research evidence to be considered together with the views, experiences
and tacit knowledge of those who will be involved in, or affected by, future decisions about a high-
priority issue. Increasing interest in the use of policy dialogues has been fuelled by a number of
factors: 1. The recognition of the need for locally contextualised 'decision support' for
policymakers and other stakeholders 2. The recognition that research evidence is only one input
into the decision-making processes of policymakers and other stakeholders 3. The recognition that
many stakeholders can add significant value to these processes, and 4. The recognition that many
stakeholders can take action to address high-priority issues, and not just policymakers. In this
article, we suggest questions to guide those organising and using policy dialogues to support
evidence-informed policymaking. These are: 1. Does the dialogue address a high-priority issue? 2.
Does the dialogue provide opportunities to discuss the problem, options to address the problem,
and key implementation considerations? 3. Is the dialogue informed by a pre-circulated policy brief
and by a discussion about the full range of factors that can influence the policymaking process? 4.
Does the dialogue ensure fair representation among those who will be involved in, or affected by,
future decisions related to the issue? 5. Does the dialogue engage a facilitator, follow a rule about
not attributing comments to individuals, and not aim for consensus? 6. Are outputs produced and
follow-up activities undertaken to support action?
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About STP
This article is part of a series written for people responsible for
making decisions about health policies and programmes and for
those who support these decision makers. The series is intended
to help such people ensure that their decisions are well-informed
by the best available research evidence. The SUPPORT tools
and the ways in which they can be used are described in more
detail in the Introduction to this series [1]. A glossary for the
entire series is attached to each article (see Additional File 1).
Links to Spanish, Portuguese, French and Chinese translations
of this series can be found on the SUPPORT website http://
www.support-collaboration.org. Feedback about how to
improve the tools in this series is welcome and should be sent to:
STP@nokc.no.
Scenarios
Scenario 1: You are a senior civil servant and have been invited
to a policy dialogue about an issue that is of growing interest to
the Minister. You are concerned about whether the policy dia-
logue is being organised in way that will inform different ele-
ments of the issue, and recognises the importance of drawing on
both research evidence and stakeholder views and experiences.
You also want to ensure that the policy dialogue does not con-
clude with a recommendation that is politically or economically
unfeasible and hence potentially awkward for the Minister con-
cerned.
Scenario 2: You work in the Ministry of Health and have been
given a few hours to prepare an assessment of a planning doc-
ument for a policy dialogue that will address a high-priority
issue for the Ministry. All that you have been told is that this
policy dialogue is different in a number of ways from the type
of stakeholder engagement processes that you have organised in
the past for the Ministry, including how it will be informed by
a pre-circulated summary of the best available research evi-
dence on the problem, options to address it, and implementa-
tion considerations.
Scenario 3: You work in an independent unit that supports the
Ministry of Health in its use of research evidence in policymak-
ing. You are organising a policy dialogue for senior Ministry
officials and key stakeholders to deliberate about a problem,
options to address it, and implementation considerations. You
have been told to organise the policy dialogue in a way that is
likely to enhance its potential impact, but you want guidance on
how to do so.
Background
For policymakers (Scenario 1), this article suggests a
number of questions that they might ask their staff to con-
sider when deciding whether to participate in a policy dia-
logue or how to maximise the value of a policy dialogue
that they are sponsoring. For those who support policy-
makers (Scenarios 2 and 3), this article suggests a number
of questions to guide their assessment of a plan for a pol-
icy dialogue or their organisation of one.
There has been growing interest in identifying interactive
knowledge-sharing mechanisms that allow research evi-
dence to be brought together with the views, experiences
and tacit knowledge of those who will be involved in, or
affected by, future decisions about high-priority issues
[2,3]. This interest has been fuelled by a number of devel-
opments:
1. The recognition of the need for locally contextualised
'decision support' for policymakers and other stakehold-
ers [4,5]
2. The recognition that research evidence is only one input
into the decision-making processes of policymakers and
other stakeholders [6,7]
3. The recognition that many stakeholders can add signif-
icant value to these processes [8,9], and
4. The recognition that many stakeholders can take action
to address high-priority issues - not just policymakers
Policy dialogues constitute a promising 'interactive
knowledge-sharing mechanism'. The development of
these dialogues has been informed, at least in part, by
findings from two systematic reviews of the factors influ-
encing the use of research evidence in policymaking
[10,11]. While the reviews identified that research in this
field was not extensive, rigorous or consistent, a few fac-
tors did emerge consistently:
• Higher levels of interaction between researchers and
policymakers increased the likelihood of research evi-
dence being used (particularly when the interactions were
based on informal relationships). Conversely, a lack of
interaction decreased the likelihood of research evidence
being used
￿ Timeliness increased the likelihood of research evidence
being used in policymaking, while a lack of timeliness
decreased this likelihood
￿ The likelihood of research evidence being used in poli-
cymaking increased when available research evidence
accorded with the beliefs, values, interests or political
goals and strategies of politicians, civil servants and stake-
holders (or when particular political stances had not yet
been decided). Conversely, a lack of accord decreased the
probability of research evidence being used.Health Research Policy and Systems 2009, 7(Suppl 1):S14 http://www.health-policy-systems.com/content/7/S1/S14
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Policy dialogues have the potential to improve the use of
research by shaping the factors listed above. This potential
can be realised through support related directly to:
1. Interactions between researchers and policymakers
(and among a wider range of stakeholders who are able to
take action)
2. The timely identification and interpretation of the
available research evidence (when a policy dialogue is
organised urgently to address a high-priority issue), and
3. The 'real time' identification of accord between research
evidence and the beliefs, values, interests or political goals
and strategies of policymakers and stakeholders.
Table 1 provides a simple framework for distinguishing
the differences between 'dialogue' and 'debate'. While dia-
logue is the goal of policy dialogues, debate does not typi-
cally offer suitable opportunities for the support of
constructive interaction and the identification of shared
ground. This does not mean that debate does not have a
critical and complementary role in policymaking. Indeed,
forums are also needed to enable contesting value posi-
tions to be articulated. In these, the extent and quality of
the research evidence supporting alternative problem def-
initions, options, and implementation strategies (sup-
ported by very different value positions) can be publicly
presented and debated.
Models for policy dialogues can be distinguished in three
ways both from each other and from other stakeholder
engagement processes in terms of their:
￿ Goals - which can include information sharing, net-
working, discussion, consensus statement development,
and action planning about related goals and/or processes
￿ Group composition, and
￿ Group processes - which can includes pre- and post-cir-
culated materials and format (e.g. concurrent delibera-
tions in several groups or sequential deliberations in a
single group, and rules)
Considerable attention has been paid to these distinctions
(and their implications) in public engagement initiatives
[12,13] and in clinical practice guideline development
[14-16]. For example, researchers have developed an evi-
dence base to inform choices about the design of guide-
line development processes. This includes approaches to
panel composition, the format of pre-circulated evidence
summaries, and consensus rules [17].
Far less attention has been given to the benefits, harms
and costs of alternative approaches to policy dialogues
that seek to support evidence-informed policymaking, or
to support other types of evidence-informed action
related to health systems. A systematic review found no
rigorous evaluations of the effects of policy dialogues [3].
However, the review did identify a variety of policy dia-
logue characteristics that appear promising, including
consultation with all parties affected by an outcome, the
fair representation of scientists and stakeholders, high-
quality syntheses of the scientific evidence, and skilful
chairing [2,3]. Our own formative evaluation of a policy
dialogue that involved policymakers, civil society groups
and researchers from 20 low- and middle-income coun-
tries found that pre-circulated evidence summaries,
skilled facilitation, the application of the Chatham House
Rule (prohibiting the attribution of particular com-
ments), and a lack of emphasis on achieving consensus,
were among the highly-valued design features [18].
Questions to consider
The following questions can guide how to organise and
use policy dialogues to support evidence-informed policy-
making:
1. Does the dialogue address a high-priority issue?
2. Does the dialogue provide opportunities to discuss the
problem, options to address the problem, and key imple-
mentation considerations?
3. Is the dialogue informed by a pre-circulated policy brief
and by a discussion about the full range of factors that can
influence the policymaking process?
4. Does the dialogue ensure fair representation among
those who will be involved in, or affected by, future deci-
sions related to the issue?
Table 1: Differences between dialogue and debate
Dialogue Debate
Collaborative Oppositional
Common ground Winning
Enlarges perspectives Affirms perspectives
Searches for agreement Searches for differences
Causes introspection Causes critique
Looks for strengths Looks for weaknesses
Re-evaluates assumptions Defends assumptions
Listening for meaning Listening for countering
Remains open-ended Implies a conclusion
Source: Adapted from the Co-Intelligence Institute and appearing in 
Jones CM, Mittelmark MB. The IUHPE Blueprint for Directed and 
Sustained Dialogue for Partnership InitiativesHealth Research Policy and Systems 2009, 7(Suppl 1):S14 http://www.health-policy-systems.com/content/7/S1/S14
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5. Does the dialogue engage a facilitator, follow a rule
about not attributing comments to individuals, and not
aim for consensus?
6. Are outputs produced and follow-up activities under-
taken to support action?
1. Does the dialogue address a high-priority issue?
Policy dialogues should ideally address an issue consid-
ered high priority by some or all stakeholders. If a partic-
ular issue has been on the agenda of key stakeholders for
some time, then policy dialogues, like policy briefs (dis-
cussed further in Article 13 in this series), may act as a way
to spur action [19]. The Evidence-Informed Policy Net-
work (EVIPNet) in both Burkina Faso and Cameroon, for
example, convened a national policy dialogue to address
the long-standing challenge of low coverage rates for
artemisinin-based combination therapies (ACT) to treat
uncomplicated falciparum malaria. If an issue in a policy
brief is relatively new, then the associated policy dialogue
may potentially play an agenda-setting role. But irrespec-
tive of whether it does so or not, the focus of a policy dia-
logue would always ideally be an issue deemed to be a
priority by at least some key stakeholders.
The process of obtaining consensus on the selection of a
priority issue for a policy dialogue, however, may leave
organisers hostage to policymakers and stakeholders who
support the status quo or are seeking to avoid change.
Issues related to obtaining consensus on how a problem
can best be clarified or options best framed, may also priv-
ilege those seeking to avoid change. Such groups may be
also be privileged by the choice of dialogue invitees or
facilitator, and decisions related to follow-up activities to
support action. (These concerns from the focus of Ques-
tions 2 to 6 below).
While our focus in this article is primarily on policy dia-
logues organised with the active engagement of existing
political regimes, other policy dialogue scenarios are pos-
sible. These may include dialogues organised by those
working with opposition leaders, 'shadow' health minis-
ters, and others who might not share the prevailing ortho-
doxy about what constitutes a high-priority issue or a
feasible set of approaches to addressing it.
Because of the way in which priorities change, the timing
of policy dialogues is also often critical. In order to
address issues when they are considered a high priority
and 'windows of opportunity' for change are evident, it
may be necessary to organise policy dialogues rapidly.
2. Does the dialogue provide opportunities to discuss the 
problem, options to address the problem, and key 
implementation considerations?
Policy dialogues, like policy briefs, focus on:
1. Different features of a problem, including (where pos-
sible) how it affects particular groups
2. Options to address the problem, and
3. Key implementation considerations
During policy dialogues, participants may conclude that
none of the options are optimal. In these instances, they
may advocate 'borrowing' additional features from other
options in order to create a new hybrid (or 'bundled')
option. Dialogues may also be convened at different
stages of the policymaking process, giving greater focus to
problem definition earlier in the process and to implemen-
tation later.
Policy briefs present the best available synthesised research
evidence. But (as described in Article 13 in the series) they
do not speak explicitly to potential actions based on that
evidence [19]. Policy dialogues, in contrast, can do this.
The focus, in these instances, could be on working
through what actions can be taken individually (by a poli-
tician, for example) and collectively  (by a coalition, for
instance, of health professional associations). The fact
that this may be done 'collectively', however, does not
imply that everyone will be included. It may instead mean
that only several of the groups whose members are partic-
ipating in a policy dialogue will move forward collec-
tively. And as we discuss below, consensus on the type of
collective action chosen is usually not actively sought.
3. Is the dialogue informed by a pre-circulated policy brief 
and by a discussion about the full range of factors that can 
influence the policymaking process?
A policy brief, as described in Article 13 in this series, is a
highly efficient way of introducing global and  local
research evidence about a problem [19]. It also provides
options to address a problem, as well as introducing key
implementation considerations to dialogue participants.
The goal of a policy dialogue is to support the full discus-
sion of relevant considerations (including research evi-
dence) about a high-priority issue in order to inform
policymaking and other types of action. Dialogues pro-
vide a vehicle for harnessing many types of information
and creating locally contextualised knowledge that can
inform policymaking and other types of action.
To ensure that key relevant research evidence is taken into
account, it is important to have policy briefs pre-circu-
lated. This is also critical because policy briefs provideHealth Research Policy and Systems 2009, 7(Suppl 1):S14 http://www.health-policy-systems.com/content/7/S1/S14
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common ground from which discussions about the issues
can be launched. At the start of each set of deliberations
(about a problem, options and implementation consider-
ations, respectively), highlights from the corresponding
section of a policy brief may be introduced informally.
These final highlights would ideally be informally pre-
sented and discussed. The alternative of a more formal
method of presentation may give some participants the
impression that research evidence constitutes the sole
focus of the deliberations, or takes precedence over other
considerations. A final round of deliberations focusing on
who may be able to support the implementation of possi-
ble actions has no corresponding written section in a pol-
icy brief.
While research evidence can be codified in the form of a
policy brief, it is perhaps the views, experiences and tacit
knowledge of those who will be involved in, or affected
by, future decisions about a high-priority issue that can
best emerge spontaneously in the course of a policy dia-
logue. Dialogue participants would ideally be invited to
introduce their own understanding about factors that
need to be considered. These include on-the-ground real-
ities and constraints, the values and beliefs of citizens and
communities, the power dynamics among interest groups,
institutional constraints, and considerations related to
'external' factors (such as the broader economy or, in the
case of low- and middle-income countries, the strategic
priorities of donors). These understandings are particu-
larly important given that they shape participant
approaches to a problem, the options they may choose to
address the problem, the implementation of the options,
and future decisions related to who should undertake par-
ticular actions.
4. Does the dialogue ensure fair representation among 
those who will be involved in or affected by future 
decisions related to the issue?
A policy dialogue would ideally bring together the many
parties involved in, or affected by, future decisions related
to a high-priority issue in order to ensure fair representa-
tion. As a first step, this requires the careful mapping of
the full range of stakeholders related to the issue at hand.
Stakeholder mapping may be achieved by creating an
inventory of role categories specific to the issue. Those
involved could include:
￿ Policymakers (including elected officials, political staff
or civil servants) in the national government and/or in
sub-national governments if independent public policy-
making authority related to the issue exists at the sub-
national level. These policymakers may be drawn from
many different departments, and not just health or
finance departments
￿ Managers in districts/regions, healthcare institutions
(e.g. hospitals), and non-governmental organisations,
and other relevant types of organisations
￿ Staff or members of civil society groups, which could
include consumer groups, health professional associa-
tions, and industry associations, among others, and
￿ Researchers in national research institutions, universi-
ties, and from other jurisdictions.
In some countries, individuals may play several of these
roles concurrently (or have played them sequentially).
As a second step, individuals will need to be carefully
selected from the role categories above. Two criteria may
be useful:
1. The ability of the individuals to articulate the views and
experiences of a particular constituency on the issue,
while constructively engaging at the same time with par-
ticipants drawn from other constituencies and learning
from them, and
2. The ability of the individuals to champion the actions
that will address the issue within their constituencies
Different political systems will have different traditions
relating to which individuals - and how many individuals
- will be invited to meetings to discuss high-priority issues.
It may or may not be possible, or desirable, to adapt a tra-
dition for a specific policy dialogue. But when determin-
ing the number of invitees, a key consideration should be
the balanced representation of all key constituencies, on
one hand, and the opportunity for all individuals to con-
tribute, on the other hand. A total of between fifteen and
twenty participants might achieve such a balance for some
issues and in some contexts. A group twice this size might
be needed for other issues and in other contexts. In some
French-speaking African countries, for example, EVIPNet
teams have organised policy dialogues that were even
larger (this is discussed further in Table 2). In order to
allow all individuals to contribute in these instances, the
local organisers included frequent concurrent delibera-
tions among subgroups.
Invitation letters to policy dialogue can prove critical to
engaging key individuals. The title for a policy dialogue
would ideally be worded in a way that will engage invited
policymakers and stakeholders and may, for example,
take the form of a compelling question. The invitation let-
ter would ideally provide a list of those involved in plan-
ning the dialogue and a list of funders (of the organisation
convening the dialogue and of the dialogue itself), as well
as their affiliations.Health Research Policy and Systems 2009, 7(Suppl 1):S14 http://www.health-policy-systems.com/content/7/S1/S14
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5. Does the dialogue engage a facilitator, follow a rule 
about not attributing comments to individuals, and not 
aim for consensus?
A skilled, knowledgeable and neutral facilitator is
required to ensure that a policy dialogue is run well. Skill
is needed to keep the deliberations focused on the issue at
hand, to ensure that all dialogue participants have a voice
in the deliberations, and to challenge constructively any
possible misinterpretations of the issue under discussion,
and evidence of the other factors that may influence deci-
sion making. It is particularly important for the facilitator
to guard against the possibility that perceptions about the
relative status of participants (whether based on position
in an organisation, educational background or other fac-
tors) or other considerations such as language barriers, do
not privilege some participants in the dialogue over oth-
ers. An intermediate level of knowledge about the issue at
hand and the local context is required in order to interpret
the contributions of the policy brief and to manage the
dynamics during the deliberations. Neutrality is also
required in order to ensure that all participants perceive
the dialogue as a 'safe harbour' for deliberation and not as
a vehicle for facilitators to steer deliberations in a direc-
tion that they may prefer.
Arranging such a safe space for deliberation requires some
commonly agreed rules to reassure individuals that they
may speak frankly and without fear of repercussion in the
media - or elsewhere - for having done so. Many policy
dialogues follow the Chatham House Rule: "Participants
are free to use the information received during the meet-
ing, but neither the identity nor the affiliation of the
speaker(s), nor that of any other participant, may be
revealed" http://www.chathamhouse.org.uk/about/
chathamhouserule/. This rule ensures that dialogue par-
ticipants feel empowered to act on what they have learned
while knowing that their contributions will not be used to
hurt them in the future.
Not aiming for consensus may seem paradoxical at first.
But this is an important provision for many policymakers
and stakeholders. Policymakers are ultimately responsible
for setting policies. Therefore, while actual policy develop-
ment typically occurs through a complex set of interac-
tions involving government officials and stakeholders,
most policymakers would be very hesitant to commit
themselves to one approach after only a single dialogue,
or without the opportunity to confer with policymakers in
other parts of government or with other stakeholders.
Similarly, some stakeholders will need to return to their
groups or organisations in order to decide what actions
the groups or organisations should take. All of this said,
although seeking consensus may not be an appropriate
goal in most contexts, consensus can and probably should
be embraced if it emerges spontaneously.
6. Are outputs produced and follow-up activities 
undertaken to support action?
Action to improve health is the preferred outcome for pol-
icy dialogues, and therefore mechanisms are needed to
equip both dialogue participants and others with the tools
to support such action. As a minimum, both the policy
brief and a high-level summary of the policy dialogue (i.e.
a summary of key points rather than a detailed report)
should be actively disseminated. The dialogue summary
would need to remain true to the Chatham House Rule
that requires comments not to be attributed to identified
individuals or to individuals with identified affiliations.
Under this same rule, the dialogue summary may not
include a list of dialogue participants.
Additional steps can also be taken to support any required
action. For example, the McMaster Health Forum, a uni-
versity-based convenor of policy dialogues:
1. Offers dialogue participants the opportunity to partici-
pate in a brief video interview in which they can describe
the insights drawn from the dialogue, or the actions they
see as critical to addressing a high-priority issue. At the
same time, it is made clear to them that their personal
choice to relax the way in which the Chatham House Rule
applies to them does not alter the way in which the rule
applies to others
2. Offers a personalised briefing about the implications of
the dialogue to key stakeholder groups in order to support
Table 2: Policy dialogues about improving malaria treatment
Two EVIPNet teams, one in Burkina Faso and one in Cameroon, convened national policy dialogues to support a full discussion of relevant 
considerations (including research evidence) about how to support the widespread use of artemisinin-based combination therapy to treat 
uncomplicated falciparum malaria.
The dialogue in Burkina Faso brought together 38 stakeholders in May 2008 to discuss this problem, three options to address it, and key 
implementation considerations. The insights derived from the policy dialogue directly informed the preparation of the Burkina Faso government's 
successful application to the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Held in January 2009, the dialogue in Cameroon included almost twice the number of stakeholders involved in Burkina Faso, and worked through 
the particular features of the same problem of malaria treatment in Cameroon, three options appropriate to the problem, as well as related 
implementation considerations. This group was divided into four smaller 'working groups' for each set of deliberations. The dialogue received 
significant media attention and increased the likelihood of meaningful action in the following months.Health Research Policy and Systems 2009, 7(Suppl 1):S14 http://www.health-policy-systems.com/content/7/S1/S14
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their understanding of what the policy brief and dialogue
summary mean for them, and
3. Offers a year-long evidence service that brings to atten-
tion newly published or newly identified systematic
reviews. This provides added momentum to proposed
actions or the need for changes. The video interviews and
evidence service are all posted on the Forum's website to
inspire and inform others.
As with all efforts in this nascent domain, such follow-up
activities warrant further evaluation.
Over time, consideration can be given to how policy dia-
logues might 'fit' with the rest of an evidence-informed
policymaking process and whether they can become the
norm for important issues.
Conclusion
Policy dialogues represent a new and evolving approach
to supporting evidence-informed policymaking. They are
one of many forms of political interaction that could use-
fully be more evidence-informed. The organisation and
use of policy dialogues continues to evolve through prac-
tical experience. Evaluations of this approach are needed
in order to improve our understanding of which particular
design features and follow-up activities are well received
for particular types of issues and in particular types of con-
texts. For example, the Chatham House Rule may be per-
ceived as being particularly important for highly
politicised topics. Similarly, the objective of not aiming for
consensus may be perceived as inappropriate in political
systems that have a long tradition of civil society engage-
ment in policymaking. Evaluations are also necessary as a
way of improving our understanding of whether, and
how, policy dialogues and related follow-up activities
support evidence-informed policymaking. Table 3 pro-
vides a description of one approach to the formative eval-
uation of policy dialogues.
Resources
Useful documents and further reading
- Lomas J, Culyer T, McCutcheon C, McAuley L, Law S:
Conceptualizing and Combining Evidence for Health System
Table 3: An example of an approach to the formative evaluation of policy dialogues
• The McMaster Health Forum surveys participants in all of the policy dialogues it convenes and has the long-term goal of identifying which particular 
design features work best for which particular types of issues and in which types of health system contexts. Participation is voluntary, confidentiality 
is assured, and anonymity safe-guarded
• Dialogues are characterised by twelve features and these are the focus of the questions in the formative evaluation survey. A dialogue:
• Addresses a high-priority issue
• Provides an opportunity to discuss different features of the problem, including (where possible) how these affect particular groups
• Provides an opportunity to discuss three options to address the policy issue
• Provides an opportunity to discuss key implementation considerations
• Provides an opportunity to discuss who might take what action
• Is informed by a pre-circulated evidence brief that mobilises both global and local research evidence about the problem, three options to 
address the problem, and key implementation considerations
• Is informed by a discussion about the full range of factors that can inform how to approach the problem, options to address the problem, and 
the implementation of these options
• Brings together many parties who would be involved in, or affected by, future decisions related to the issue
• Ensures fair representation among policymakers, stakeholders, and researchers
• Engages a facilitator to assist with the deliberations
• Allows for frank, off-the-record deliberations by following the Chatham House Rule: "Participants are free to use the information received 
during the meeting, but neither the identity nor the affiliation of the speaker(s), nor that of any other participant, may be revealed", and
• Does not aim for consensus
• For each design feature the survey asks:
• How useful did they find this approach on a scale ranging from 1 (Worthless) to 7 (Useful)?
• Comments and suggestions for improvement?
• The survey also asks:
• How well did the policy dialogue achieve its purpose, namely to support a full discussion of relevant considerations (including research 
evidence) about a high-priority issue in order to inform action on a scale from 1 (Failed) to 7 (Achieved)?
• What features of the dialogue should be retained in future?
• What features of the dialogue should be changed in future?
• What others can do better or differently to address the high-priority issue and what they personally can do better or differently?
• Their role and background 
(so that the McMaster Health Forum can determine if different groups have different views about, and experiences with, the dialogues)
• The McMaster Health Forum also plans to conduct brief follow-up surveys six months after a dialogue, with the objective of identifying what, if 
any, actions have been undertaken by dialogue participants and what, if any, impacts have been achieved. Here again, participation is voluntary, 
confidentiality is assured, and anonymity safeguarded
• The Evidence-Informed Policy Networks (EVIPNet) operating in Africa, Asia and the Americas plan to use a similar approach in the formative 
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Guidance. Ottawa, Canada: Canadian Health Services
Research Foundation; 2005 [3]http://www.chsrf.ca/
other_documents/pdf/evidence_e.pdf
Links to websites
- Chatham House: http://www.chathamhouse.org.uk -
Source of the 'Chatham House Rule'
- Evidence-Informed Policy Networks: http://www.evip
net.org - Network of groups involved in convening
national policy dialogues.
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